Clinical Data on Finerenone in Diabetic Kidney Disease

Opinion
Video

Dr George Bakris reviews the clinical trial data for finerenone and provides insights on treatment selection, including the potential benefits of combination therapy with finerenone and SGLT2 inhibitors, in managing diabetic kidney disease.

Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Related Content
Brendon Neuen, MBBS, PhD | Credit: X.Com

SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events

April 18th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Elena Christofides, MD | Credit: Endocrinology Associates

Insulin Glargine Biosimilar Demonstrates Bioequivalence to Originator for Type 2 Diabetes

April 13th 2024
Article
Alan Lotvin, MD | Credit: X.com

Diabetes Dialogue: What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD

March 30th 2024
Podcast
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024
Article
Endocrinology Month in Review: March 2024 thumbnail featuring HCOLive endocrinology logo

Endocrinology Month in Review: March 2024

April 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.